Diffuse large B-cell lymphoma: open trials in Israel

8 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06091865
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Samson Assuta Ashdod University Hospital, Ashdod · Bnai Zion Medical Center, Haifa · Hadassah medical Center, Jerusalem · Galilee Medical Center, Nahariya · The Tel Aviv Sourasky Medical Center, Tel Aviv · The Chaim Sheba Medical Center, Tel-Hashomer
Registry updated 2026-11-04
NCT05139017
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Emek Medical Center-Hematology Unit ( Site 1102), Afula · Carmel Hospital ( Site 1103), Haifa · Hadassah Medical Center ( Site 1100), Jerusalem
Registry updated 2026-11-03
NCT06890884
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Soroka Medical Center ( Site 0606), Beersheba · Rambam Health Care Campus ( Site 0604), Haifa · Edith Wolfson Medical Center ( Site 0602), Holon · Haddasah Medical Center ( Site 0601), Jerusalem · Rabin Medical Center ( Site 0607), Petah Tikva · Sheba Medical Center ( Site 0603), Ramat Gan · ZIV Medical Center ( Site 0605), Safed · Sourasky Medical Center ( Site 0608), Tel Aviv
Registry updated 2026-11-03
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus-Pediatric Hemato-Oncology ( Site 1674), Haifa · Sheba Medical Center ( Site 1675), Ramat Gan
Registry updated 2026-10-30
NCT07249905
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Trial Treatment · Phase 1/2 · ModeX Therapeutics, An OPKO Health Company
Rambam Medical Center, Haifa · Hadassah medical Center, Jerusalem · Rabin Medical Center- Beilinson Hospital, Petah Tikva · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-10-28
NCT06717347
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Carmel Hospital ( Site 1903), Haifa · Hadassah Medical Center ( Site 1901), Jerusalem · Sourasky Medical Center ( Site 1904), Tel Aviv · Poria Medical Center ( Site 1902), Tiberias
Registry updated 2026-10-21
NCT05735704
Early Detection and Screening of Hematological Malignancies - SANGUINE
Research · JaxBio Ltd
Tel Aviv Sourasky Medical Center - TASMC, Tel Aviv
Registry updated 2026-10-15
NCT06830759
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Research · AbbVie
Hadassah Medical Center-Hebrew University /ID# 271616, Jerusalem · Rabin Medical Center. /ID# 271614, Petah Tikva · Tel Aviv Sourasky Medical Center /ID# 271615, Tel Aviv
Registry updated 2026-02-17

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error